The authors report two cases of Bipolar Affective Disorder which were responsive to Lithium therapy in the past, but could no longer be treated with Lithium due to hyperparathyroidism in the first case and noncompliance in the second. In both cases, successful control of hypomania was achieved with Verapamil, but treatment of depression required the addition of Trazodone. The rationale for employing a calcium channel blocking agent, such as Verapamil, in bipolar illness is reviewed.
References
1.
SinghB.N., EllrodtG., PeterC.T.Verapamil: a review of its pharmacological properties and therapeutic use.Drugs1978; 15: 169–197.
2.
CarmanJ.S., WyattR.J.Calcium: pacesetting the periodic psychoses.Am J Psychiatry1979; 136: 1035–1039.
3.
CarmanJ.S., WyattR.J.Calcium: bivalent cation in the bivalent psychoses.Biol Psychiatry1979; 14: 295–336.
4.
JimersonD.C.CSF calcium: clinical correlates in affective illness and schizophrenia.Biol Psychiatry1979; 14: 37–51.
5.
DubovskyS.L., FranksR.D.Intracellular calcium ions in affective disorders: a review and an hypothesis.Biol Psychiatry1983; 18: 781–797.
6.
GianniniA.J.Antimanic effects of verapamil.Am J Psychiatry1984; 141: 1602–1603.
7.
HoschlC.Letter to the editor; Verapamil for depression:Am J Psychiatry1983; 140: 1100.
8.
GitlinM.J., WeissJ.Verapamil as maintenance treatment in bipolar illness: a case report.J Clin Psychopharmacol1984; 4: 341–343.
9.
MauritsonD.R.Oral verapamil for paroxysmal supraventricular tachycardia. A long-term, double-blind randomized trial.Ann Intern Med1982; 96: 409–412.
